Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AOAH intronic transcript 1 (AOAH-IT1) is a non-protein-coding gene classified as a long non-coding RNA (lncRNA), transcribed entirely within an intron of the AOAH gene, which encodes acyloxyacyl hydrolase[1][3]. According to current classifications, AOAH-IT1 does not code for a protein and is not characterized as an enzyme, receptor, transporter, or similar actionable therapeutic target[1][3]. Like many lncRNAs, its function remains largely uncharacterized, but lncRNAs often act as regulators of gene expression, both in "cis" (on neighboring genes) and "trans" (on distant loci)[3]. No direct evidence links AOAH-IT1 to particular biological functions, disease roles, or drug interactions. If more detailed characterization, biological function, or disease association emerges in future literature, further updates may be possible; currently, information on AOAH-IT1 is limited to its status as an intronic lncRNA gene[1][3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AOAH intronic transcript 1 (AOAH-IT1).